INVERNIZZI PIETRO

Role
Professore ordinario
Academic disciplines
Gastroenterologia (MED/12)
Room:
  • U08, Floor: 3, Room: 3019

Publications

  • Yang, Y., Choi, J., Chen, Y., Invernizzi, P., Yang, G., Zhang, W., et al. (2022). E. coli and the etiology of human PBC: Antimitochondrial antibodies and spreading determinants. HEPATOLOGY, 75(2), 266-279 [10.1002/hep.32172]. Dettaglio

  • Gemelli, M., Carbone, M., Abbate, M., Mancin, M., Zucchini, N., Colonese, F., et al. (2022). Vanishing bile duct syndrome following pembrolizumab infusion: case report and review of the literature. IMMUNOTHERAPY, 14(4 (1 March 2022)), 175-181 [10.2217/imt-2021-0078]. Dettaglio

  • Ongaro, A., Violatto, M., Casarin, E., Pellerani, I., Marchini, G., Ribaudo, G., et al. (2022). The mode of dexamethasone decoration influences avidin-nucleic-acid-nano-assembly organ biodistribution and in vivo drug persistence. NANOMEDICINE, 40(February 2022) [10.1016/j.nano.2021.102497]. Dettaglio

  • Massironi, S., Cavalcoli, F., Elvevi, A., Quatrini, M., & Invernizzi, P. (2022). Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study. ENDOCRINE, 75(3), 942-948 [10.1007/s12020-021-02915-7]. Dettaglio

  • Mazza, S., Piazza, O., Conforti, F., Fasci, A., Rimondi, A., Marinoni, B., et al. (2022). Safety and clinical efficacy of the double switch from originator infliximab to biosimilars CT-P13 and SB2 in patients with inflammatory bowel diseases (SCESICS): A multicenter cohort study. CLINICAL AND TRANSLATIONAL SCIENCE, 15(1), 172-181 [10.1111/cts.13131]. Dettaglio

Awards

Research and teaching assignments

  • Professore a contratto - Medicina Interna - Università degli Studi di MILANO, 2008